The Pathogenicity and Synergistic Action of Th1 and Th17 Cells in Inflammatory Bowel Diseases
Inflammatory Bowel Diseases · 02.05.2023 · 29 (5) · 818-829
DOI: 10.1093/ibd/izac199 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Inflammatory Bowel Diseases, online erschienen am 27.09.2022. Verfasst von Hui Cao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Inflammatory Bowel Diseases, Colitis. Die Arbeit wurde bisher 85-mal zitiert (Crossref) und nennt 138 Literaturangaben. Gefördert von: Shanghai Municipal Health Commission, Shanghai Municipal Administrator of Traditional Chinese Medicine.
Abstract (Originalsprache)
Inflammatory bowel diseases (IBDs), including ulcerative colitis and Crohn’s disease, are characterized by chronic idiopathic inflammation of gastrointestinal tract. Although the pathogenesis of IBD remains unknown, intestinal immune dysfunction has been considered as the core pathogenesis. In the intestinal immune system, T helper 1 (Th1) and Th17 cells are indispensable for intestine homeostasis via preventing pathogenic bacteria invasion, regulating metabolism and functions of intestinal epithelial cells (IECs), and promoting IEC self-renewal. However, during the development of IBD, Th1 and Th17 cells acquire the pathogenicity and change from the maintainer of intestinal homeostasis to the destroyer of intestinal mucosa. Because of coexpressing interferon-γ and interleukin-17A, Th17 cells with pathogenicity are named as pathogenic Th17 cells. In disease states, Th1 cells impair IEC programs by inducing IEC apoptosis, recruiting immune cells, promoting adhesion molecules expression of IECs, and differentiating to epithelial cell adhesion molecule–specific interferon γ–positive Th1 cells. Pathogenic Th17 cells induce IEC injury by triggering IBD susceptibility genes expression of IECs and specifically killing IECs. In addition, Th1 and pathogenic Th17 cells could cooperate to induce colitis. The evidences from IBD patients and animal models demonstrate that synergistic action of Th1 and pathogenic Th17 cells occurs in the diseases development and aggravates the mucosal inflammation. In this review, we focused on Th1 and Th17 cell programs in homeostasis and intestine inflammation and specifically discussed the impact of Th1 and Th17 cell pathogenicity and their synergistic action on the onset and the development of IBD. We hoped to provide some clues for treating IBD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
- Department of Pediatrics, Yueyang Hospital of Chinese Integrative Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
- Department of Acupuncture and Moxibustion, Shanghai Jiading Hospital of Traditional Chinese Medicine, Shanghai, China.
- Institute of Digestive Diseases, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Förderung
- Shanghai Municipal Health Commission
- Shanghai Municipal Administrator of Traditional Chinese Medicine
Zitieren
APA
Cao, H., Diao, J., Liu, H., Liu, S., Liu, J., Yuan, J., & Lin, J. (2023). The Pathogenicity and Synergistic Action of Th1 and Th17 Cells in Inflammatory Bowel Diseases. Inflammatory Bowel Diseases, 29(5), 818-829. https://doi.org/10.1093/ibd/izac199
Vancouver
Cao H, Diao J, Liu H, Liu S, Liu J, Yuan J, et al. The Pathogenicity and Synergistic Action of Th1 and Th17 Cells in Inflammatory Bowel Diseases. Inflammatory Bowel Diseases. 2023;29(5):818-829. doi:10.1093/ibd/izac199
BibTeX
@article{Cao2023,
author = {Cao, Hui and Diao, Jun and Liu, Huosheng and Liu, Suxian and Liu, Jun and Yuan, Jianye and Lin, Jiang},
title = {The Pathogenicity and Synergistic Action of Th1 and Th17 Cells in Inflammatory Bowel Diseases},
journal = {Inflammatory Bowel Diseases},
year = {2023},
volume = {29},
number = {5},
pages = {818--829},
doi = {10.1093/ibd/izac199}
}
EUVIMED